OOIR: Observatory of International Research

Papers

(The median citation count of Chemotherapy is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview	37
The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities	32
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection	22
Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study	13
Animal Hosts and Experimental Models of SARS-CoV-2 Infection	13
SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods	13
The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis	12
KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment	11
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management	10
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma	10
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life	10
Curcumin Suppresses the Progression of Colorectal Cancer by Improving Immunogenic Cell Death Caused by Irinotecan	9
A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib	8
miR-142-3p Regulates Tumor Cell Autophagy and Promotes Colon Cancer Progression by Targeting TP53INP2	8
Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy	8
Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients	8
Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	7
Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients	6
Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer	6
Detection of NDM-1 and VIM Genes in Carbapenem-Resistant <b><i>Klebsiella pneumoniae</i></b> Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal	6
Venetoclax in Combination with Hypomethylating Agents for the Treatment of Treatment-Naive B/Myeloid Mixed-Phenotype Acute Leukemia and Relapsed/Refractory Acute Myeloid Leukemia: A Report of 3 Cases	5
Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer	5
The Effect of High CDC6 Levels on Predicting Poor Prognosis in Colorectal Cancer	4
Quercetin Inhibits Glioblastoma Growth and Prolongs Survival Rate through Inhibiting Glycolytic Metabolism	4
Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis	4

Synthesis and Antimicrobial Evaluation of Amino Acid Naphthoquinone Derivatives as Potential Antibacterial Agents	4
miR-466 Contributes to the Enhanced Antitumor Effect of Bortezomib on Non-Small-Cell Lung Cancer by Inhibiting CCND1	4
Ibrutinib and Bruton’s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac Death	4
Efficacy and Safety of Super-Selective Bronchial Arterial Infusion Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer	3
Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis	3
Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review	3
Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant <b><i>Acinetobacter baumannii</i></b> Isolates of Clinical Origin	3
Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple Myeloma	3
Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma	3
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma	3
Lung Adenocarcinoma Harboring Triple Rare EGFR Exon 18 Mutations Rapidly Developed Resistance to Multiple Therapies	2
Safety Signal between Azacitidine and Pericarditis	2
The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report	2
Acute Hepatitis E Infection during Chemotherapy for Lung Cancer: A Case Report	2
Metastatic Renal Cell Carcinoma Classified as Good Risk: The Easiest Choice Has Become the Hardest	2
Novel Tetrazoles against Acanthamoeba castellanii Belonging to the T4 Genotype	2
Fulminant Type 1 Diabetes Mellitus Caused by Long-Term Nivolumab Administration Followed by Nivolumab plus Cabozantinib Combination	2
Safety and Survival Outcomes in Lung Cancer Patients Receiving Carboplatin: Impact of Uncapped Dosage	1
Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report	1
The Impact of COVID-19 Pandemic on Cancer’s Patients and Their Access to Chemotherapy in Iraq	1
Initial Therapeutic Approach with Pembrolizumab in Synchronous Multiple Cancers, Including Non-Small Cell Lung Cancer, Highly Positive for Programmed Death-Ligand 1 Expression	1
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature	1
Occupational Safety in Chemosensitivity Tests: A Method to Minimize the Risk of Contamination While Maximizing the Safety for the Examiner	1
Circulating Endothelial Cell Kinetic in Patients with Multiple Myeloma Who Receive Autologous Hematopoietic Stem Cell Transplantation	1
Fusidic Acid and Its Major Active Metabolite Penetration into Cerebrospinal Fluid for Assessing Treatment of Intracranial Infections	1
Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil	1
Investigation of the Physical Properties and Clinical Application of Embosphere Microspheres	1
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report	1
Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer	1
Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia	1
Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients	1
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities	1
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regi	1
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment	1
Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an <i>AUC</i><sub><i>24</i></sub> Target in Critically Ill Patients	1
Drug Interactions Causing Warfarin Overdose in a Patient with Pancreatic Cancer: A Case Report	1
Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	1
Two Novel Mutations Associated with Polymyxin-B Resistance in a Pandemic Lineage of Uropathogenic <b><i>Escherichia coli</i></b> of the Sequence Type 69	1
Front & Back Matter	0
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma	0
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing <b><i>Escherichia coli</i></b> Isolates	0
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group	0
Contents Vol. 67, 2022	0
Does the Timing of Eribulin Treatment for Advanced or Metastatic Breast Cancer Matter? Evidence from a Real-World Setting	0
Targeted Therapy of Non-Small Cell Lung Cancer and Liver Cancer: Functional Nanocarriers for the Delivery of Cisplatin and Tissue Factor Pathway Inhibitor-2	0
Natural Compounds with Antimicrobial Activities in Oral Candida Infections during Head and Neck Radiotherapy	0
Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy	0
Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	0
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation	0
Acknowledgement to Reviewers	0

Initiating Treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion	0
Front & Back Matter	0
Secreted frizzled-related protein 4 induces gastric cancer progression and resistance to cisplatin and oxaliplatin via β-catenin dysregulation	0
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatin	0
Efficacy of PD-1 Inhibitors in First-Line Treatment for Advanced Gastroesophageal Junction and Gastric Cancer by Subgroups: A Systematic Review and Meta-Analysis	0
Risk of Immune-Related Pneumonitis with PD-1/PD-L1 Inhibitors in Different Cancer Types and Treatment Regimens: A Systematic Review and Meta-Analysis of 22 Randomized Controlled Trials	0
Front & Back Matter	0
Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients	0
Quo Vadis COVID? Lessons from a Focus Topic Issue of Chemotherapy	0
Front & Back Matter	0
Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades	0
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA	0
Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy	0
Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis	0
Hepatosplenic T-Cell Non-Hodgkin Lymphoma Cured with Tandem Autologous and Allogeneic Stem Cell Transplantation	0
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report	0
Molecular Characterization, Virulence Determinants, and Antimicrobial Resistance Profile of Methicillin-Resistant <b><i>Staphylococcus aureus</i></b> in the North of Iran; a Hi	0
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant	0
Body Mass Index of Elderly Patients with Normal Renal Function as a Determining Factor for Initial Vancomycin Regimen Designing	0
Arrhythmia in Bruton Tyrosine Kinase Inhibitor-Treated Patients: Unanswered Questions	0
Pneumocystis Jiroveci Pneumonia Secondary to Blinatumomab Therapy: A Case Report	0
Front & Back Matter	0
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer: Impact of Tumor Ki67 and ER Status	0
Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells	0
Front & Back Matter	0
Changing and evolution of influenza virus: is it a trivial flu?	0
Fluorodeoxyglucose-Positron Emission Tomography in Relapsed/Refractory Hodgkin Lymphoma: A Practical Approach	0
Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience	0
Paraneoplastic Demyelinating Inflammatory Neuropathy Revealing Metastatic Seminoma: A Case Report	0
Front & Back Matter	0
Front & Back Matter	0
Erratum	0
3–4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy Cycles	0
Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1<sup>mut</sup>-AML Who Has Become Ineligible for	0
Acknowledgement to Reviewers	0
Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma	0
Front & Back Matter	0
Meningococcal Conjunctivitis in a 54-Year-Old Man: Case Report and Review of the Literature	0
A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab	0
A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with Prognosis	0
Front & Back Matter	0
SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution	0
Front & Back Matter	0
Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression	0
Contents Vol. 68, 2023	0
The Synergistic Inhibitory Effect of Combining MK-2206 and AZD 6244 in MARIMO Cells Harboring a Calreticulin Gene Mutation	0
Acknowledgement to Reviewers	0
<i>Kodamaea ohmeri</i> Leg Skin Ulcer Infection in an Immunocompetent Patient: A Case Report	0
Treatment with Brivudine in Immunocompromised Pediatric Patients with Herpes Zoster	0
New Perspectives for Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type	0
Contents, Vol. 66, 2021	0
Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy	0